AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+1.16%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.73B
AUM Growth
+$1.73B
(-9.5%)
Cap. Flow
+$946K
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
45.72%
Holding
140
New
9
Increased
17
Reduced
13
Closed
14
Top Buys
| 1 |
AGEN
Agenus
AGEN
|
$25.2M |
| 2 |
Revolution Medicines
RVMD
|
$23.8M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$23M |
| 4 |
Vor Biopharma
VOR
|
$15.5M |
| 5 |
Kymera Therapeutics
KYMR
|
$12.5M |
Top Sells
| 1 |
argenx
ARGX
|
$53M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$47.9M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
$18.9M |
| 4 |
Solid Biosciences
SLDB
|
$11.2M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$11M |
Sector Composition
| 1 | Healthcare | 95.14% |
| 2 | Consumer Discretionary | 3.86% |
| 3 | Real Estate | 0.4% |
| 4 | Financials | 0.24% |
| 5 | Industrials | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
26
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $21.4M | 1.2% | 1,000,000 +250,000 | +33% | +$5.35M |
|
27
Kura Oncology
KURA
$686M
| $21.1M | 1.18% | 1,700,000 +600,000 | +55% | +$7.45M |
|
28
Wave Life Sciences
WVE
$1.53B
| $21M | 1.17% | 3,000,000 | – | – |
|
29
Erasca
ERAS
$445M
| $20.3M | 1.13% | 4,710,682 +1,538,461 | +48% | +$6.63M |
|
|
30
Vor Biopharma
VOR
$250M
| $19.1M | 1.07% | 2,875,581 +2,325,581 | +423% | +$15.5M |
|
31
Replimune Group
REPL
$422M
| $19M | 1.06% | 700,000 -200,000 | -22% | -$5.44M |
|
32
Schrodinger
SDGR
$1.44B
| $13.1M | 0.73% | 700,000 | – | – |
|
|
OMGA
33
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $13M | 0.72% | 2,273,530 | – | – |
|
34
Mersana Therapeutics
MRSN
$36.5M
| $12.9M | 0.72% | 2,200,000 | – | – |
|
35
Avidity Biosciences
RNA
$5.99B
| $11.1M | 0.62% | 500,000 +250,000 | +100% | +$5.55M |
|
36
Generation Bio
GBIO
$40.4M
| $11.1M | 0.62% | 2,814,191 | – | – |
|
37
Foghorn Therapeutics
FHTX
$286M
| $11M | 0.61% | 1,720,720 | – | – |
|
38
Travere Therapeutics
TVTX
$1.56B
| $10.5M | 0.59% | +500,000 | New | +$10.5M |
|
39
Repare Therapeutics
RPTX
$71.7M
| $10.3M | 0.57% | 700,000 | – | – |
|
40
Insmed
INSM
$28.8B
| $9.99M | 0.56% | +500,000 | New | +$9.99M |
|
41
Intellia Therapeutics
NTLA
$1.22B
| $9.6M | 0.54% | 275,000 | – | – |
|
42
Evotec
EVO
$1.24B
| $9.3M | 0.52% | 1,149,425 | – | – |
|
43
Sea Limited
SE
$110B
| $8.98M | 0.5% | 172,500 | – | – |
|
|
ALPN
44
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $8.77M | 0.49% | 1,193,030 | – | – |
|
45
Natera
NTRA
$23.1B
| $8.03M | 0.45% | 200,000 +100,000 | +100% | +$4.02M |
|
46
iTeos Therapeutics
ITOS
| $7.81M | 0.44% | 400,000 | – | – |
|
47
Recursion Pharmaceuticals
RXRX
$2.04B
| $7.4M | 0.41% | 960,204 +510,204 | +113% | +$3.93M |
|
48
Gossamer Bio
GOSS
$562M
| $7.05M | 0.39% | 3,246,624 | – | – |
|
49
KE Holdings
BEKE
$20.8B
| $6.98M | 0.39% | +500,000 | New | +$6.98M |
|
50
Biohaven
BHVN
$1.63B
| $6.94M | 0.39% | +500,000 | New | +$6.94M |
|